Intratumoral Genomic Heterogeneity May Hinder Precision Medicine Strategies in Patients with Serous Ovarian Carcinoma

Intratumoral Genomic Heterogeneity May Hinder Precision Medicine Strategies in Patients with Serous Ovarian Carcinoma

Precision medicine, which includes comprehensive genome sequencing, is a potential therapeutic option for treating high-grade serous carcinoma (HGSC). However, HGSC is a heterogeneous tumor at the architectural, cellular, and molecular levels. Intratumoral molecular heterogeneity currently limits th...

Full description

Bibliographic Details
Main Authors: Kohei Nakamura, Eriko Aimono, Shigeki Tanishima, Mitsuho Imai, Akiko Kawano Nagatsuma, Hideyuki Hayashi, Yuki Yoshimura, Kentaro Nakayama, Satoru Kyo, Hiroshi Nishihara
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Diagnostics
Subjects:
ovarian carcinoma
genomic heterogeneity
precision medicine
DNA sequencing
Online Access:https://www.mdpi.com/2075-4418/10/4/200

Internet

https://www.mdpi.com/2075-4418/10/4/200

Similar Items